Related Experiment Video

Updated: Jul 5, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

[Antiretroviral drug toxicity in human immunodeficiency virus infected children]

E Núñez Cuadros1, M J Mellado Peña, M Rivera Cuello

  • 1Servicio de Pediatría, Hospital Carlos III, Madrid, España. esmeraldanunez@hotmail.com

Anales De Pediatria (Barcelona, Spain : 2003)
|May 2, 2008
PubMed

Insights

Paediatric Human Immunodeficiency Virus (HIV) infection management requires lifelong antiretroviral therapy, but adverse drug effects significantly impact quality of life. This study details metabolic toxicities in four children with HIV and offers therapeutic strategies.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Pharmacology
  • Metabolic Disorders

Background:

  • Paediatric Human Immunodeficiency Virus (HIV) infection is now a chronic condition requiring lifelong combined antiretroviral treatment (cART).
  • While cART improves survival, adverse drug effects significantly limit quality of life in children with HIV.
  • Metabolic complications are a major concern, impacting long-term health and treatment adherence.

Observation:

  • Four paediatric patients with HIV presented with a wide spectrum of metabolic toxicities.
  • These toxicities included hyperlipemia, lipodystrophy, insulin resistance, lactic acidosis, osteopenia, and hypertension.
  • Organ-specific toxicities affecting the kidney, liver, central nervous system (CNS), and bone marrow were also observed.

Findings:

  • The metabolic costs of cART, such as increased cardiovascular disease risk and bone mass damage, are significant.
  • Adverse drug effects can lead to pharmacological interferences and patient intolerance.
  • High drug burden complicates adherence, which is critical for therapeutic efficacy.

Implications:

  • Effective management of metabolic toxicities is crucial for improving the quality of life in children with HIV.
  • Understanding and addressing these toxicities can enhance treatment adherence and long-term outcomes.
  • This case series provides a practical overview for managing complex metabolic complications in paediatric HIV patients.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...